Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCPK - Delayed Quote USD

Wesana Health Holdings Inc. (WSNAF)

Compare
0.0205
0.0000
(0.00%)
At close: April 17 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
4/30/2021
Cost of Revenue
--
--
--
185.6460
--
Gross Profit
--
--
--
81.5590
--
Operating Expense
424.1630
1,104.6520
3,277.3800
4,676.0330
36.8504
Operating Income
-424.1630
-1,104.6520
-3,277.3800
-4,676.0330
-36.8504
Net Non Operating Interest Income Expense
-74.9070
16.3870
-18.4960
-19.0260
--
Other Income Expense
-44.2380
-939.2680
129.4820
-1,647.3800
--
Pretax Income
-543.3080
-2,027.5330
-3,166.3940
-6,342.4390
-36.8504
Net Income Common Stockholders
-1,133.0640
-1,723.1710
-8,599.2710
-34,339.1160
-147.9865
Diluted NI Available to Com Stockholders
-1,133.0640
-1,723.1710
-8,599.2710
-34,339.1160
-147.9865
Basic EPS
-0.03
-0.05
-0.25
-1.48
-0.01
Diluted EPS
-0.03
-0.05
-0.25
-1.48
-0.01
Basic Average Shares
35,039.3930
35,039.3930
34,380.3100
23,152.7290
12,578.9970
Diluted Average Shares
35,039.3930
35,039.3930
34,380.3100
23,152.7290
12,578.9970
Total Expenses
424.1630
1,104.6520
3,277.3800
4,676.0330
36.8504
Net Income from Continuing & Discontinued Operation
-1,133.0640
-1,723.1710
-8,599.2710
-34,339.1160
-147.9865
Normalized Income
-499.0700
-1,088.2650
-3,160.0940
-4,695.0600
-147.9865
Interest Income
-63.3700
23.9660
56.6740
--
--
Interest Expense
11.5370
7.5790
75.1700
19.0260
--
Net Interest Income
-74.9070
16.3870
-18.4960
-19.0260
--
EBIT
-531.7710
-2,019.9540
-3,091.2240
-6,323.4130
-36.8504
EBITDA
-531.7710
-2,019.9540
-3,091.2240
-6,323.4130
-36.8504
Reconciled Cost of Revenue
--
--
--
185.6460
--
Reconciled Depreciation
--
--
--
53.3300
--
Net Income from Continuing Operation Net Minority Interest
-543.3080
-2,027.5330
-3,166.3940
-6,342.4400
-147.9865
Total Unusual Items Excluding Goodwill
-44.2380
-939.2680
-6.3000
-1,647.3800
--
Total Unusual Items
-44.2380
-939.2680
-6.3000
-1,647.3800
--
Normalized EBITDA
-487.5330
-1,080.6860
-3,084.9240
-4,676.0330
-36.8504
4/30/2021 - 6/4/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

G28.F Tevogen Bio Holdings Inc.
0.8800
-1.79%
 
CINGW Cingulate Inc.
0.0448
+0.22%
 
TVGNW Tevogen Bio Holdings Inc.
0.0482
+5.01%
 
OMGAQ
0.0550
+10.00%
 
BIXT Bioxytran, Inc.
0.1794
+11.43%
 
ABP Abpro Holdings, Inc.
0.2580
+4.88%
 
PXMD PaxMedica, Inc.
0.0001
0.00%
 
VIRX Viracta Therapeutics, Inc.
0.0150
-25.00%
 
ENTX Entera Bio Ltd.
1.7900
+1.70%
 
SILO Silo Pharma, Inc.
1.0748
+4.35%